Lista de obras -

A multicenter phase II study of erlotinib and sorafenib in chemotherapy-naive patients with advanced non-small cell lung cancer

artículo científico publicado en 2010

Absolute Quantification of [11C]docetaxel Kinetics in Lung Cancer Patients Using Positron Emission Tomography

scientific article published on 12 July 2011

An 82-year-old woman with small-cell lung cancer: relapse after 9 years or a new primary?

artículo científico publicado en 2012

Analysis of AKT and ERK1/2 protein kinases in extracellular vesicles isolated from blood of patients with cancer.

artículo científico publicado en 2014

Assessment of simplified methods to measure 18F-FLT uptake changes in EGFR-mutated non-small cell lung cancer patients undergoing EGFR tyrosine kinase inhibitor treatment.

artículo científico publicado en 2014

Biodistribution and radiation dosimetry of 11C-labelled docetaxel in cancer patients

artículo científico publicado en 2010

Close Surveillance with Long-Term Follow-up of Subjects with Preinvasive Endobronchial Lesions.

artículo científico publicado en 2015

Complete pathological response is predictive for clinical outcome after tri-modality therapy for carcinomas of the superior pulmonary sulcus

artículo científico publicado en 2013

Cost-Utility of Stepped Care Targeting Psychological Distress in Patients With Head and Neck or Lung Cancer.

artículo científico publicado en 2016

DNA copy number aberrations in endobronchial lesions: a validated predictor for cancer

scientific article published on 13 November 2013

Detecting resistance in EGFR-mutated non-small-cell lung cancer after clonal selection through targeted therapy.

artículo científico publicado en 2015

Development of [(11)C]erlotinib positron emission tomography for in vivo evaluation of EGF receptor mutational status.

artículo científico publicado en 2012

Dramatic response to low-dose erlotinib of epidermal growth factor receptor mutation-positive recurrent non-small cell lung cancer after severe cutaneous toxicity

artículo científico publicado en 2009

EGFR mutation analysis in sputum of lung cancer patients: a multitechnique study

artículo científico publicado en 2013

Early prediction of nonprogression in advanced non-small-cell lung cancer treated with erlotinib by using [(18)F]fluorodeoxyglucose and [(18)F]fluorothymidine positron emission tomography.

artículo científico publicado en 2011

Effects of erlotinib therapy on [(11)C]erlotinib uptake in EGFR mutated, advanced NSCLC.

artículo científico publicado en 2016

Evaluation of a cumulative SUV-volume histogram method for parameterizing heterogeneous intratumoural FDG uptake in non-small cell lung cancer PET studies

artículo científico publicado en 2011

Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids

artículo científico publicado en 2018

Is the current diagnostic algorithm reliable for selecting cases for EGFR- and KRAS-mutation analysis in lung cancer?

artículo científico publicado en 2015

Long-term expanding human airway organoids for disease modeling

scientific article published on 14 January 2019

Measuring response to therapy using FDG PET: semi-quantitative and full kinetic analysis

artículo científico publicado en 2011

Methodological considerations in quantification of 3'-deoxy-3'-[18F]fluorothymidine uptake measured with positron emission tomography in patients with non-small cell lung cancer

artículo científico publicado en 2014

Negative NKX2-1 (TTF-1) as Temporary Surrogate Marker for Treatment Selection During EGFR-Mutation Analysis in Patients with Non–Small-Cell Lung Cancer

artículo científico publicado en 2012

Parametric methods for quantification of 18F-FAZA kinetics in non-small cell lung cancer patients

artículo científico

Pharmacokinetic analysis of [18F]FAZA in non-small cell lung cancer patients.

artículo científico publicado en 2013

Prolonged sampling of spontaneous sputum improves sensitivity of hypermethylation analysis for lung cancer.

artículo científico publicado en 2012

Proteome analysis of non-small cell lung cancer cell line secretomes and patient sputum reveals biofluid biomarker candidates for cisplatin response prediction

artículo científico publicado en 2019

Quantitative and Simplified Analysis of 11C-Erlotinib Studies

artículo científico publicado en 2016

Rapid decrease in delivery of chemotherapy to tumors after anti-VEGF therapy: implications for scheduling of anti-angiogenic drugs.

artículo científico publicado en 2012

Reproducibility of quantitative 18F-3'-deoxy-3'-fluorothymidine measurements using positron emission tomography

artículo científico publicado en 2008

Reproducibility of tumor perfusion measurements using 15O-labeled water and PET.

artículo científico publicado en 2008

Sorafenib in patients with advanced non-small cell lung cancer that harbor K-ras mutations: a brief report

artículo científico publicado en 2010

Stepped care targeting psychological distress in head and neck and lung cancer patients: a randomized clinical trial

artículo científico publicado en 2012

Stepped care targeting psychological distress in head and neck cancer and lung cancer patients: which groups specifically benefit? Secondary analyses of a randomized controlled trial

artículo científico publicado en 2019

Toward prediction of efficacy of chemotherapy: a proof of concept study in lung cancer patients using [¹¹C]docetaxel and positron emission tomography.

artículo científico publicado en 2013

Lista de obras de

A multicenter phase II study of erlotinib and sorafenib in chemotherapy-naive patients with advanced non-small cell lung cancer

Absolute Quantification of [11C]docetaxel Kinetics in Lung Cancer Patients Using Positron Emission Tomography

An 82-year-old woman with small-cell lung cancer: relapse after 9 years or a new primary?

Analysis of AKT and ERK1/2 protein kinases in extracellular vesicles isolated from blood of patients with cancer.

Assessment of simplified methods to measure 18F-FLT uptake changes in EGFR-mutated non-small cell lung cancer patients undergoing EGFR tyrosine kinase inhibitor treatment.

Biodistribution and radiation dosimetry of 11C-labelled docetaxel in cancer patients

Close Surveillance with Long-Term Follow-up of Subjects with Preinvasive Endobronchial Lesions.

Complete pathological response is predictive for clinical outcome after tri-modality therapy for carcinomas of the superior pulmonary sulcus

Cost-Utility of Stepped Care Targeting Psychological Distress in Patients With Head and Neck or Lung Cancer.

DNA copy number aberrations in endobronchial lesions: a validated predictor for cancer

Detecting resistance in EGFR-mutated non-small-cell lung cancer after clonal selection through targeted therapy.

Development of [(11)C]erlotinib positron emission tomography for in vivo evaluation of EGF receptor mutational status.

Dramatic response to low-dose erlotinib of epidermal growth factor receptor mutation-positive recurrent non-small cell lung cancer after severe cutaneous toxicity

EGFR mutation analysis in sputum of lung cancer patients: a multitechnique study

Early prediction of nonprogression in advanced non-small-cell lung cancer treated with erlotinib by using [(18)F]fluorodeoxyglucose and [(18)F]fluorothymidine positron emission tomography.

Effects of erlotinib therapy on [(11)C]erlotinib uptake in EGFR mutated, advanced NSCLC.

Evaluation of a cumulative SUV-volume histogram method for parameterizing heterogeneous intratumoural FDG uptake in non-small cell lung cancer PET studies

Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids

Is the current diagnostic algorithm reliable for selecting cases for EGFR- and KRAS-mutation analysis in lung cancer?

Long-term expanding human airway organoids for disease modeling

Measuring response to therapy using FDG PET: semi-quantitative and full kinetic analysis

Methodological considerations in quantification of 3'-deoxy-3'-[18F]fluorothymidine uptake measured with positron emission tomography in patients with non-small cell lung cancer

Negative NKX2-1 (TTF-1) as Temporary Surrogate Marker for Treatment Selection During EGFR-Mutation Analysis in Patients with Non–Small-Cell Lung Cancer

Parametric methods for quantification of 18F-FAZA kinetics in non-small cell lung cancer patients

Pharmacokinetic analysis of [18F]FAZA in non-small cell lung cancer patients.

Prolonged sampling of spontaneous sputum improves sensitivity of hypermethylation analysis for lung cancer.

Proteome analysis of non-small cell lung cancer cell line secretomes and patient sputum reveals biofluid biomarker candidates for cisplatin response prediction

Quantitative and Simplified Analysis of 11C-Erlotinib Studies

Rapid decrease in delivery of chemotherapy to tumors after anti-VEGF therapy: implications for scheduling of anti-angiogenic drugs.

Reproducibility of quantitative 18F-3'-deoxy-3'-fluorothymidine measurements using positron emission tomography

Reproducibility of tumor perfusion measurements using 15O-labeled water and PET.

Sorafenib in patients with advanced non-small cell lung cancer that harbor K-ras mutations: a brief report

Stepped care targeting psychological distress in head and neck and lung cancer patients: a randomized clinical trial

Stepped care targeting psychological distress in head and neck cancer and lung cancer patients: which groups specifically benefit? Secondary analyses of a randomized controlled trial

Toward prediction of efficacy of chemotherapy: a proof of concept study in lung cancer patients using [¹¹C]docetaxel and positron emission tomography.